Exploring the potential of nanocarriers in antipsoriatic therapeutics

References

• Sala M, Elaissari A, Fessi H. Advances in psoriasis physiopathology and treatments: up to date of mechanistic insights and perspectives of novel therapies based on innovative skin drug delivery systems (ISDDS)). J Control Release. 2016;239:182–202.
   PubMed Web of Science ®Google Scholar
• Lo Y, Tsai TF. Updates on the treatment of erythrodermic psoriasis. Psoriasis. 2021;11:59–73.
   PubMed Web of Science ®Google Scholar
• Xie J, Huang S, Huang H, et al. Advances in the application of natural products and the novel drug delivery systems for psoriasis. Front Pharmacol. 2021;12:644952.
   PubMed Web of Science ®Google Scholar
• Mabuchi T, Chang TW, Quinter S, et al. Chemokine receptors in the pathogenesis and therapy of psoriasis. J Dermatol Sci. 2012;65(1):4–11.
   PubMed Web of Science ®Google Scholar
• Pradhan M, Singh D, Singh MR. Novel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approaches. J Control Release. 2013;170(3):380–395.
   PubMed Web of Science ®Google Scholar
• Traub M, Marshall K. Psoriasis–pathophysiology, conventional, and alternative approaches to treatment. Altern Med Rev. 2007;12(4):319–330.
   PubMedGoogle Scholar
• Gordon-Elliott JS, Muskin PR. Managing the patient with psychiatric issues in dermatologic practice. Clin Dermatol. 2013;31(1):3–10.
   PubMed Web of Science ®Google Scholar
• Fraga NA, Oliveira MD, Follador I, et al. Psoriasis and uveitis: a literature review. An Bras Dermatol. 2012;87(6):877–883.
   PubMed Web of Science ®Google Scholar
• Singh A, Easwari TS. Recent advances in psoriasis therapy: trends and future prospects. Curr Drug Targets. 2021;22(15):1760–1771.
   PubMed Web of Science ®Google Scholar
• Yan BX, Chen XY, Ye LR, et al. Cutaneous and systemic psoriasis: classifications and classification for the distinction. Front Med. 2021;8:649408.
   Google Scholar
• Rajguru JP, Maya D, Kumar D, et al. Update on psoriasis: a review. J Family Med Prim Care. 2020;9(1):20–24.
   PubMedGoogle Scholar
• Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clin Med. 2021;21(3):170–173.
   PubMed Web of Science ®Google Scholar
• Umezawa Y. Psoriatic arthritis. J Dermatol. 2021;48(6):741–749.
   PubMed Web of Science ®Google Scholar
• Bachelez H. Pustular psoriasis: the dawn of a new era. Acta Derm Venereol. 2020;100(3):adv00034.
   PubMed Web of Science ®Google Scholar
• Saleh D, Tanner LS. Guttate psoriasis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021.
   Google Scholar
• Crowley JJ, Weinberg JM, Wu JJ, et al. Treatment of nail psoriasis: best practice recommendations from the Medical Board of the National Psoriasis Foundation. JAMA Dermatol. 2015;151(1):87–94.
   PubMed Web of Science ®Google Scholar
• Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945–1960.
   PubMed Web of Science ®Google Scholar
• Garg T, Rath G, Goyal AK. Ancient and advanced approaches for the treatment of an inflammatory autoimmune disease − psoriasis. Crit Rev Ther Drug Carrier Syst. 2014;31(4):331–364.
   Google Scholar
• Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. IJMS. 2019;20(6):1475.
   Web of Science ®Google Scholar
• Greb JE, Goldminz AM, Elder JT, et al. Psoriasis. Nat Rev Dis Primers. 2016;2:16082.
   PubMed Web of Science ®Google Scholar
• Louden BA, Pearce DJ, Lang W, et al. A simplified psoriasis area severity index (SPASI) for rating psoriasis severity in clinic patients. Dermatol Online J. 2004;10(2):7.
   PubMedGoogle Scholar
• Buechler CR, Veenstra J, Stein Gold L. New topical therapies for psoriasis. Dermatol Rev. 2021;2(5):262–267.
   Google Scholar
• Gungor S, Rezigue M. Nanocarriers mediated topical drug delivery for psoriasis treatment. Curr Drug Metab. 2017;18(5):454–468.
   PubMed Web of Science ®Google Scholar
• Rahman M, Alam K, Ahmad MZ, et al. Classical to current approach for treatment of psoriasis: a review. Endocr Metab Immune Disord Drug Targets. 2012;12(3):287–302.
   PubMedGoogle Scholar
• Ashcroft DM, Li Wan Po A, Griffiths CE. Therapeutic strategies for psoriasis. J Clin Pharm Ther. 2000;25(1):1–10.
   PubMed Web of Science ®Google Scholar
• Yadav K, Soni A, Singh D, et al. Polymers in topical delivery of anti-psoriatic medications and other topical agents in overcoming the barriers of conventional treatment strategies. Prog Biomater. 2021;10(1):1–17.
   PubMed Web of Science ®Google Scholar
• Kuchekar AB, Pujari RR, Kuchekar SB, et al. Psoriasis: a comprehensive review. Int J Life Sci. 2011;2(6).
   Google Scholar
• Nordin UU, Ahmad N, Salim N, et al. Lipid-based nanoparticles for psoriasis treatment: a review on conventional treatments, recent works, and future prospects. RSC Adv. 2021;11(46):29080–29101.
   PubMed Web of Science ®Google Scholar
• Ali F, Neha K, Sharma K, et al. Nanotechnology-based medicinal products and patents: a promising way to treat psoriasis. Curr Drug Deliv. 2022;19.
   PubMed Web of Science ®Google Scholar
• Yu YQ, Yang X, Wu XF, et al. Enhancing permeation of drug molecules across the skin via delivery in nanocarriers: novel strategies for effective transdermal applications. Front Bioeng Biotechnol. 2021;9:200.
   Web of Science ®Google Scholar
• Reid C, Griffiths CEM. Psoriasis and treatment: past, present and future aspects. Acta Derm Venereol. 2020;100(3):adv00032.
   PubMedGoogle Scholar
• Pandey K, Nimisha . An overview on promising nanotechnological approaches for the treatment of psoriasis. Recent Pat Nanotechnol. 2020;14(2):102–118.
   PubMed Web of Science ®Google Scholar
• Kushwaha P, Saxena S, Shukla B. A recent overview on dermatological applications of liposomes. Recent Pat Nanotechnol. 2021;15(4):310–321.
   PubMed Web of Science ®Google Scholar
• Pradhan M, Alexander A, Singh MR, et al. Understanding the prospective of nano-formulations towards the treatment of psoriasis. Biomed Pharmacother. 2018;107:447–463.
   PubMed Web of Science ®Google Scholar
• Jyothi SL, Krishna KL, Shirin VKA, et al. Drug delivery systems for the treatment of psoriasis: current status and prospects. J Drug Deliv Sci Technol. 2021;62:102364.
   Web of Science ®Google Scholar
• Garg T, Rath G, Goyal AK. Nanotechnological approaches for the effective management of psoriasis. Artif Cells Nanomed Biotechnol. 2016;44(6):1374–1382.
   PubMed Web of Science ®Google Scholar
• Chlapanidas T, Perteghella S, Leoni F, et al. TNF-α blocker effect of naringenin-loaded sericin microparticles that are potentially useful in the treatment of psoriasis. Int J Mol Sci. 2014;15(8):13624–13636.
   PubMed Web of Science ®Google Scholar
• Priyanka NS, Neeraja P, Mangilal T, et al. Formulation and evaluation of gel loaded with microspheres of apremilast for transdermal delivery system. Asian J Pharm Clin Res. 2019;12:411–417.
   Google Scholar
• Zielińska A, Carreiró F, Oliveira AM, et al. Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology. Molecules. 2020;25(16):3731.
   PubMed Web of Science ®Google Scholar
• Soliman G, Shaaban O, Hamdan AM. Preparation and evaluation of anthralin biodegradable nanoparticles as a potential delivery system for the treatment of psoriasis. Int J Pharm Pharm Sci. 2015;7(12):36–40.
   Google Scholar
• Mao KL, Fan ZL, Yuan JD, et al. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model. Colloids Surf B Biointerfaces. 2017;160:704–714.
   PubMed Web of Science ®Google Scholar
• Anwer MK, Mohammad M, Ezzeldin E, et al. Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats. Int J Nanomedicine. 2019;14:1587–1595.
   PubMed Web of Science ®Google Scholar
• Kumar S, Prasad M, Rao R. Topical delivery of clobetasol propionate loaded nanosponge hydrogel for effective treatment of psoriasis: Formulation, physicochemical characterization, antipsoriatic potential and biochemical estimation. Mater Sci Eng C Mater Biol Appl. 2021;119:111605.
   PubMed Web of Science ®Google Scholar
• Makhmalzade BS, Chavoshy F. Polymeric micelles as cutaneous drug delivery system in normal skin and dermatological disorders. J Adv Pharm Technol Res. 2018;9(1):2–8.
   PubMed Web of Science ®Google Scholar
• Jin Y, Zhang X, Zhang B, et al. Nanostructures of an amphiphilic zinc phthalocyanine polymer conjugate for photodynamic therapy of psoriasis. Colloids Surf B Biointerfaces. 2015;128:405–409.
   PubMed Web of Science ®Google Scholar
• Chavoshy F, Zadeh BS, Tamaddon AM, et al. Delivery and anti-psoriatic effect of silibinin-loaded polymeric micelles: an experimental study in the psoriatic skin model. Curr Drug Deliv. 2020;17(9):787–798.
   PubMed Web of Science ®Google Scholar
• Khurana B, Arora D, Narang RK. QbD based exploration of resveratrol loaded polymeric micelles based carbomer gel for topical treatment of plaque psoriasis: in vitro, ex vivo and in vivo studies. J Drug Deliv Sci Technol. 2020;59(59):101901.
   Google Scholar
• Dinshaw IJ, Ahmad N, Salim N, et al. Nanoemulsions: a review on the conceptualization of treatment for psoriasis using a green surfactant with low-energy emulsification method. Pharmaceutics. 2021;13(7):1024.
   PubMed Web of Science ®Google Scholar
• Algahtani MS, Ahmad MZ, Ahmad J. Nanoemulsion loaded polymeric hydrogel for topical delivery of curcumin in psoriasis. J Drug Deliv Sci Technol. 2020;59:101847.
   Web of Science ®Google Scholar
• Kaur A, Katiyar SS, Kushwah V, et al. Nanoemulsion loaded gel for topical co-delivery of clobitasol propionate and calcipotriol in psoriasis. Nanomedicine. 2017;13(4):1473–1482.
   PubMed Web of Science ®Google Scholar
• Sahu S, Katiyar SS, Kushwah V, et al. Active natural oil-based nanoemulsion containing tacrolimus for synergistic antipsoriatic efficacy. Nanomedicine. 2018;13(16):1985–1998.
   PubMed Web of Science ®Google Scholar
• Batheja P, Sheihet L, Kohn J, et al. Topical drug delivery by a polymeric nanosphere gel: Formulation optimization and in vitro and in vivo skin distribution studies. J Control Release. 2011;149(2):159–167.
   PubMed Web of Science ®Google Scholar
• Kilfoyle BE, Sheihet L, Zhang Z, et al. Development of paclitaxel-TyroSpheres for topical skin treatment. J Control Release. 2012;163(1):18–24.
   PubMed Web of Science ®Google Scholar
• Knudsen NØ, Rønholt S, Salte RD, et al. Calcipotriol delivery into the skin with PEGylated liposomes. Eur J Pharm Biopharm. 2012;81(3):532–539.
   PubMed Web of Science ®Google Scholar
• Srisuk P, Thongnopnua P, Raktanonchai U, et al. Physico-chemical characteristics of methotrexate-entrapped oleic acid-containing deformable liposomes for in vitro transepidermal delivery targeting psoriasis treatment. Int J Pharm. 2012;427(2):426–434.
   PubMed Web of Science ®Google Scholar
• Gupta R, Gupta M, Mangal S, et al. Capsaicin-loaded vesicular systems designed for enhancing localized delivery for psoriasis therapy. Artif Cells Nanomed Biotechnol. 2016;44(3):825–834.
   PubMed Web of Science ®Google Scholar
• Doppalapudi S, Jain A, Chopra DK, et al. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis. Eur J Pharm Sci. 2017;96:515–529.
   PubMed Web of Science ®Google Scholar
• Walunj M, Doppalapudi S, Bulbake U, Khan W. Preparation, characterization, and in vivo evaluation of cyclosporine cationic liposomes for the treatment of psoriasis. J Liposome Res. 2020;30(1):68–79.
   Google Scholar
• Fathalla D, Youssef EM, Soliman GM. Liposomal and ethosomal gels for the topical delivery of anthralin: preparation, comparative evaluation and clinical assessment in psoriatic patients. Pharmaceutics. 2020;12(5):446.
   PubMed Web of Science ®Google Scholar
• Wang W, Shu GF, Lu KJ, et al. Flexible liposomal gel dual-loaded with all-trans retinoic acid and betamethasone for enhanced therapeutic efficiency of psoriasis. J Nanobiotechnol. 2020;18(1):1–4.
   PubMed Web of Science ®Google Scholar
• Shetty K, Sherje AP. Nano intervention in topical delivery of corticosteroid for psoriasis and atopic dermatitis – a systematic review. J Mater Sci Mater Med. 2021;32(8):88.
   PubMed Web of Science ®Google Scholar
• Parnami N, Garg T, Rath G, et al. Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy. Artif Cells Nanomed Biotechnol. 2014;42(6):406–412.
   PubMed Web of Science ®Google Scholar
• Abdelbary AA, AbouGhaly MH. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J Pharm. 2015;485(1–2):235–243.
   PubMed Web of Science ®Google Scholar
• Moghddam SR, Ahad A, Aqil M, et al. Formulation and optimization of niosomes for topical diacerein delivery using 3-factor, 3-level Box-Behnken design for the management of psoriasis. Mater Sci Eng C Mater Biol Appl. 2016;69:789–797.
   PubMed Web of Science ®Google Scholar
• Marey AA. Preparation and characterization of acitretin-loaded niosomes for psoriasis treatment [electronic theses and dissertations]. The University of Mississippi; 2017. p. 727.
   Google Scholar
• Meng S, Sun L, Wang L, et al. Loading of water-insoluble celastrol into niosome hydrogels for improved topical permeation and anti-psoriasis activity. Colloids Surf B Biointerfaces. 2019;182:110352.
   PubMed Web of Science ®Google Scholar
• Patel B, Parikh R. Preparation and formulation of transferosomes containing an antifungal agent for transdermal delivery: application of Plackett-Burman design to identify significant factors influencing vesicle size. J Pharm Bioallied Sci. 2012;4(5):60.
   PubMedGoogle Scholar
• Parkash V, Maan S, Chaudhary V, et al. Implementation of design of experiments in development and optimization of transfersomal carrier system of tacrolimus for the dermal management of psoriasis in albino wistar rat. J Bioequiv. 2018;10:98–105.
   Google Scholar
• Nimisha DA, Fatima Z, Neema CD. Antipsoriatic and anti-inflammatory studies of Berberis aristata extract loaded nanovesicular gels. Pharmacogn Mag. 2017;13(Suppl 3):S587.
   PubMedGoogle Scholar
• Bahramizadeh M, Bahramizadeh M, Kiafar B, et al. Development, characterization and evaluation of topical methotrexate-entrapped deformable liposome on imiquimod-induced psoriasis in a mouse model. Int J Pharm. 2019;569:118623.
   PubMedGoogle Scholar
• Gupta P, Jha AK, Prasad M, et al. Soft malleable vesicles: versatile carriers for efficient topical delivery of fungal therapeutics. Drug Res. 2021;71(2):54–61.
   Google Scholar
• Zhang YT, Shen LN, Wu ZH, et al. Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy. Int J Pharm. 2014;471(1–2):449–452.
   PubMed Web of Science ®Google Scholar
• Chandra A, Aggarwal G, Manchanda S, et al. Development of topical gel of methotrexate incorporated ethosomes and salicylic acid for the treatment of psoriasis. Pharm Nanotechnol. 2019;7(5):362–374.
   PubMedGoogle Scholar
• Negi P, Sharma I, Hemrajani C, et al. Thymoquinone-loaded lipid vesicles: a promising nanomedicine for psoriasis. BMC Complement Altern Med. 2019;19(1):334.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xia Q, Li Y, et al. CD44 assists the topical anti-psoriatic efficacy of curcumin-loaded hyaluronan-modified ethosomes: a new strategy for clustering drug in inflammatory skin. Theranostics. 2019;9(1):48–64.
   PubMed Web of Science ®Google Scholar
• Guo T, Lu J, Fan Y, et al. TPGS assists the percutaneous administration of curcumin and glycyrrhetinic acid coloaded functionalized ethosomes for the synergistic treatment of psoriasis. Int J Pharm. 2021;604:120762.
   PubMedGoogle Scholar
• Jain A, Doppalapudi S, Domb AJ, et al. Tacrolimus and curcumin co-loaded liposphere gel: synergistic combination towards management of psoriasis. J Control Release. 2016;243:132–145.
   PubMed Web of Science ®Google Scholar
• Jain A, Pooladanda V, Bulbake U, et al. Liposphere mediated topical delivery of thymoquinone in the treatment of psoriasis. Nanomedicine. 2017;13(7):2251–2262.
   PubMed Web of Science ®Google Scholar
• Agrawal U, Gupta M, Vyas SP. Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis. Artif Cells Nanomed Biotechnol. 2015;43(1):33–39.
   PubMed Web of Science ®Google Scholar
• Pradhan M, Singh D, Singh MR. Fabrication, optimization and characterization of triamcinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis: Application of Box Behnken design, in vitro and ex vivo studies. J Drug Deliv Sci Technol. 2017;41:325–333.
   Web of Science ®Google Scholar
• Ferreira M, Barreiros L, Segundo MA, et al. Topical co-delivery of methotrexate and etanercept using lipid nanoparticles: a targeted approach for psoriasis management. Colloids Surf B Biointerfaces. 2017;159:23–29.
   PubMed Web of Science ®Google Scholar
• Kaur N, Sharma K, Bedi N. Topical nanostructured lipid carrier based hydrogel of mometasone furoate for the treatment of psoriasis. Pharm Nanotechnol. 2018;6(2):133–143.
   PubMedGoogle Scholar
• Viegas JSR, Praça FG, Caron AL, et al. Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis. Drug Deliv Transl Res. 2020;10(3):646–660.
   PubMed Web of Science ®Google Scholar
• Pradhan M, Alexander A, Singh MR, et al. Statistically optimized calcipotriol fused nanostructured lipid carriers for effectual topical treatment of psoriasis. J Drug Deliv Sci Technol. 2021;61:102168.
   Web of Science ®Google Scholar
• Madan JR, Khobaragade S, Dua K, et al. Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast. Dermatol Ther. 2020;33(3):e13370.
   PubMed Web of Science ®Google Scholar
• Biswasroy P, Pradhan D, Kar B, et al. Recent advancement in topical nanocarriers for the treatment of psoriasis. AAPS PharmSciTech. 2021;22(5):164.
   PubMed Web of Science ®Google Scholar
• Bessar H, Venditti I, Benassi L, et al. Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis. Colloids Surf B Biointerfaces. 2016;141:141–147.
   PubMed Web of Science ®Google Scholar
• Fratoddi I, Benassi L, Botti E, et al. Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model. Nanomedicine. 2019;17:276–286.
   PubMed Web of Science ®Google Scholar
• Cerra S, Matassa R, Beltrán AM, et al. Insights about the interaction of methotrexate loaded hydrophilic gold nanoparticles: spectroscopic, morphological and structural characterizations. Mater Sci Eng C Mater Biol Appl. 2020;117:111337.
   PubMed Web of Science ®Google Scholar
• Mikhailova EO. Silver nanoparticles: mechanism of action and probable bio-application. JFB. 2020;11(4):84.
   Google Scholar
• David L, Moldovan B, Vulcu A, et al. Green synthesis, characterization and anti-inflammatory activity of silver nanoparticles using European black elderberry fruits extract. Colloids Surf B Biointerfaces. 2014;122:767–777.
   PubMed Web of Science ®Google Scholar
• Gangadevi V, Thatikonda S, Pooladanda V, et al. Selenium nanoparticles produce a beneficial effect in psoriasis by reducing epidermal hyperproliferation and inflammation. J Nanobiotechnology. 2021;19(1):101.
   PubMed Web of Science ®Google Scholar
• Sabri AH, Ogilvie J, Abdulhamid K, et al. Expanding the applications of microneedles in dermatology. Eur J Pharm Biopharm. 2019;140:121–140.
   PubMed Web of Science ®Google Scholar
• Shravanth H, Osmani RAM, Jyothi SL, et al. Microneedles-based drug delivery for the treatment of psoriasis. J Drug Deliv Sci Technol. 2021;64:102668.
   Web of Science ®Google Scholar
• Paleco R, Vučen SR, Crean AM, et al. Enhancement of the in vitro penetration of quercetin through pig skin by combined microneedles and lipid microparticles. Int J Pharm. 2014;472(1–2):206–213.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen BZ, Wang QL, et al. Fabrication of coated polymer microneedles for transdermal drug delivery. J Control Release. 2017;265:14–21.
   PubMed Web of Science ®Google Scholar
• Du H, Liu P, Zhu J, et al. Hyaluronic acid-based dissolving microneedle patch loaded with methotrexate for improved treatment of psoriasis. ACS Appl Mater Interfaces. 2019;11(46):43588–43598.
   PubMed Web of Science ®Google Scholar
• Liang L, Fei WM, Zhao ZQ, et al. Improved imiquimod-induced psoriasis like dermatitis using microneedles in mice. Eur J Pharm Biopharm. 2021;164:20–27.
   PubMed Web of Science ®Google Scholar
• Yu K, Yu X, Cao S, et al. Layered dissolving microneedles as a need-based delivery system to simultaneously alleviate skin and joint lesions in psoriatic arthritis. Acta Pharm Sin B. 2021;11(2):505–519.
   PubMed Web of Science ®Google Scholar